Format

Send to

Choose Destination
Am J Infect Control. 2015 Jan;43(1):89-91. doi: 10.1016/j.ajic.2014.10.010.

Evaluation of routine pretransplantation screening for methicillin-resistant Staphylococcus aureus in hematopoietic cell transplant recipients.

Author information

1
Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA; Department of Epidemiology, University of Washington School of Public Health, Seattle, WA.
2
Infection Prevention, Seattle Cancer Care Alliance, Seattle, WA.
3
Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA.
4
Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA; Infection Prevention, Seattle Cancer Care Alliance, Seattle, WA; Department of Medicine, University of Washington, Seattle, WA. Electronic address: spergam@fhcrc.org.

Abstract

Methicillin-resistant Staphylococcus aureus (MRSA) screening guidelines for hematopoietic cell transplant (HCT) recipients are not well defined. Retrospective assessment of standardized pretransplantation MRSA screening in a large single-center cohort of HCT recipients demonstrated that colonization was uncommon, and that no colonized patients developed posttransplantation invasive complications.

KEYWORDS:

Bacteria; Bone marrow transplant; Colonization; Infection Prevention

PMID:
25564131
PMCID:
PMC4286793
DOI:
10.1016/j.ajic.2014.10.010
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center